Research ArticleClinical Studies

Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety

TAKAE OKUNO, MASAFUMI HONGOH, RYOSUKE TANINO, TAMIO OKIMOTO, YUKARI TSUBATA and TAKESHI ISOBE
Anticancer Research June 2025, 45 (6) 2551-2561; DOI: https://doi.org/10.21873/anticanres.17627

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Blood Concentrations of Osimertinib and Its Active Metabolites: Impact on Treatment Efficacy and Safety
TAKAE OKUNO, MASAFUMI HONGOH, RYOSUKE TANINO, TAMIO OKIMOTO, YUKARI TSUBATA, TAKESHI ISOBE
Anticancer Research Jun 2025, 45 (6) 2551-2561; DOI: 10.21873/anticanres.17627
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords